AHMAD YEHYA: Open Payments
NPI 1659780013 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 60 payments from 22 companies in 2025. Trend: 2023 $1,337 · 2024 $2,259 · 2025 $1,674
Food & beverage: $1,674
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 16 | $765 |
| Abbott Laboratories | 12 | $148 |
| Amgen Inc. | 4 | $82 |
| Radius Health, Inc. | 3 | $80 |
| Neurocrine BioSciences, Inc. | 2 | $65 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Avvisto Therapeutics, LLC | 2 | $49 |
| Novo Nordisk Inc | 2 | $43 |
| BETA BIONICS, INC. | 2 | $43 |
Products named: Dexcom G6 Transmitter, FREESTYLE LIBRE, Tymlos, CRENESSITY, TEPEZZA, ISTURISA, Kerendia, CYCLOSET.
Industry payments across TX — which companies pay providers there.
